[A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of HBeAg-negative chronic hepatitis B: results at week 48].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Volumn 20, Issue 7, 2012, Pages 512-516

  Xu, Jing hang ^a   Yu, Yan yan ^b   Si, Chong wen ^b   Zeng, Zheng ^b   Zhang, Da zhi ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DRUG DERIVATIVE; ENTECAVIR; GUANINE; HEPATITIS B(E) ANTIGEN; MALEIC ACID; MALEIC ACID DERIVATIVE;

ADULT; ARTICLE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEPATITIS B; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; GUANINE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; MALE; MALEATES; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84875870982     PISSN: 10073418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)